![]() |
![]() |
My Amedeo
![]() ![]() ![]() |
![]() |
|||||||||
Stroke prevention |
Hepatitis |
Free Subscription
1 AIDS |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Hepatitis is free of charge.
Pro-fibrogenic role of alarmin HMGB1 in HIV-HBV co-infection.
AIDS. 2022 Nov 17. pii: 00002030-990000000-00152.
PubMed
Abstract available
New Therapies and Management Options for Hepatitis D.
Am J Gastroenterol. 2023 Jan 30. doi: 10.14309/ajg.0000000000002153.
PubMed
Perspectives on Adherence from the ACTG 5360 MINMON Trial: A Minimum Monitoring
Approach with 12 Weeks of Sofosbuvir/Velpatasvir in Chronic Hepatitis C
Treatment.
Clin Infect Dis. 2023 Jan 24:ciad034. doi: 10.1093.
PubMed
Abstract available
Randomised phase 2 study (JADE) of the HBV capsid assembly modulator JNJ-56136379
with or without a nucleos(t)ide analogue in patients with chronic hepatitis B
infection.
Gut. 2023 Jan 25:gutjnl-2022-328041. doi: 10.1136/gutjnl-2022-328041.
PubMed
Abstract available
Hepatitis D virus interferes with hepatitis B virus RNA production via
interferon-dependent and -independent mechanisms.
J Hepatol. 2023 Jan 23:S0168-8278(23)00016-8. doi: 10.1016/j.jhep.2023.
PubMed
Abstract available
Modelling the potential effectiveness of hepatitis C screening and treatment
strategies during pregnancy in Egypt and Ukraine.
J Hepatol. 2023 Jan 17:S0168-8278(23)00014-4. doi: 10.1016/j.jhep.2022.
PubMed
Abstract available
3P and 5P model of limited value for the detection of clinically significant
portal hypertension in patients with hepatitis delta.
J Hepatol. 2023 Jan 17:S0168-8278(23)00010-7. doi: 10.1016/j.jhep.2023.
PubMed
Clinical features, outcomes, and HLA risk factors associated with
nitrofurantoin-induced liver injury.
J Hepatol. 2023;78:293-300.
PubMed
Abstract available
MiR-155 regulates M2 polarization of hepatitis B virus-infected tumor-associated
macrophages which in turn regulates malignant progression of hepatocellular
carcinoma.
J Viral Hepat. 2023 Jan 26. doi: 10.1111/jvh.13809.
PubMed
Abstract available
A novel non-invasive model for the prediction of advanced liver fibrosis in
chronic hepatitis B patients with NAFLD.
J Viral Hepat. 2023 Jan 25. doi: 10.1111/jvh.13808.
PubMed
Abstract available
Strategies to Increase Primary Care Provider Capacity for Hepatitis C Care: The
California ECHO-PLUS Study.
J Viral Hepat. 2023 Jan 25. doi: 10.1111/jvh.13807.
PubMed
Abstract available
The association of serum immunoglobulin and complement levels and liver fibrosis
and inflammation stage in patients with chronic hepatitis B.
J Viral Hepat. 2023 Jan 25. doi: 10.1111/jvh.13810.
PubMed
Abstract available
Impact of list price changes on out-of-pocket costs and adherence in four
high-rebate specialty drugs.
PLoS One. 2023;18:e0280570.
PubMed
Abstract available
Utility of a buccal swab point-of-care test for the IFNL4 genotype in the era of
direct acting antivirals for hepatitis C virus.
PLoS One. 2023;18:e0280551.
PubMed
Abstract available
Sero-prevalence and associated factors of sexually transmitted infections among
youth-friendly services Attendees.
PLoS One. 2023;18:e0279900.
PubMed
Abstract available
Increasing liver stiffness is associated with higher incidence of hepatocellular
carcinoma in hepatitis C infection and non-alcoholic fatty liver disease-A
population-based study.
PLoS One. 2023;18:e0280647.
PubMed
Abstract available
Transcriptional responses define dysregulated immune activation in Hepatitis C
(HCV)-naive recipients of HCV-infected donor kidneys.
PLoS One. 2023;18:e0280602.
PubMed
Abstract available
Maximize Donor Cornea Use in a Hepatitis B Endemic Area via Serology Matching.
Transplantation. 2023 Jan 25. doi: 10.1097/TP.0000000000004460.
PubMed
Abstract available
Editorial on "Maximize Donor Cornea Use in a Hepatitis B Endemic Area via
Serology Matching".
Transplantation. 2023 Jan 25. doi: 10.1097/TP.0000000000004461.
PubMed
Estimating vaccination coverage for routinely recommended vaccines among children
aged 24months and adolescents aged 13 through 17years using data from
immunization information systems in the United States.
Vaccine. 2022 Nov 7. pii: S0264-410X(22)01341.
PubMed
Abstract available
A randomized phase 3 trial of the immunogenicity and safety of coadministration
of a live-attenuated tetravalent dengue vaccine (TAK-003) and an inactivated
hepatitis a (HAV) virus vaccine in a dengue non-endemic country.
Vaccine. 2023 Jan 19:S0264-410X(23)00007-5. doi: 10.1016/j.vaccine.2023.
PubMed
Abstract available
Thank you for your interest in scientific medicine.
This policy is made possible thanks to
a media sponsorship by